United States (US) Prophylactic Vaccines Market (2025-2031) | Size & Revenue, Outlook, Industry, Value, Segmentation, Forecast, Analysis, Growth, Competitive Landscape, Companies, Share, Trends

Name: United States (US) Prophylactic Vaccines Market (2025-2031) | Size & Revenue
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines), By Disease (Pneumococcal Disease, Poliovirus, Hepatitis, Influenza, Measles, Mumps, Rubella (MMR), Varicella), By Administration (Intramuscular Route, Subcutaneous Route, Oral Route, Intravenous Injection, Administration Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By End-Users (Hospitals, Homecare, Specialty Clinics) And Competitive Landscape

Product Code: ETC9974648	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Prophylactic Vaccines Market Outlook
Market Size of United States (US) Prophylactic Vaccines Market, 2024
Forecast of United States (US) Prophylactic Vaccines Market, 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Revenues & Volume for the Period 2021- 2031
United States (US) Prophylactic Vaccines Market Trend Evolution
United States (US) Prophylactic Vaccines Market Drivers and Challenges
United States (US) Prophylactic Vaccines Price Trends
United States (US) Prophylactic Vaccines Porter's Five Forces
United States (US) Prophylactic Vaccines Industry Life Cycle
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Vaccine Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Live/Attenuated Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Inactivated Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Subunit Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Toxoid Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Conjugate Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Recombinant Vector Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Disease for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Pneumococcal Disease for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Poliovirus for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Hepatitis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Influenza for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Measles for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Mumps for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Rubella (MMR) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Varicella for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Intramuscular Route for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Subcutaneous Route for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Oral Route for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Intravenous Injection for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Administration Routes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Retail Pharmacy and Online Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By End-Users for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Homecare for the Period 2021- 2031
Historical Data and Forecast of United States (US) Prophylactic Vaccines Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
United States (US) Prophylactic Vaccines Import Export Trade Statistics
Market Opportunity Assessment By Vaccine Type
Market Opportunity Assessment By Disease
Market Opportunity Assessment By Administration
Market Opportunity Assessment By Distribution Channel
Market Opportunity Assessment By End-Users
United States (US) Prophylactic Vaccines Top Companies Market Share
United States (US) Prophylactic Vaccines Competitive Benchmarking By Technical and Operational Parameters
United States (US) Prophylactic Vaccines Company Profiles
United States (US) Prophylactic Vaccines Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Prophylactic Vaccines Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Prophylactic Vaccines Market - Industry Life Cycle

3.4 United States (US) Prophylactic Vaccines Market - Porter's Five Forces

3.5 United States (US) Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

3.6 United States (US) Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F

3.7 United States (US) Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F

3.8 United States (US) Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 United States (US) Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 United States (US) Prophylactic Vaccines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing diseases

4.2.2 Government initiatives and funding to promote vaccination programs

4.2.3 Technological advancements leading to the development of more effective and efficient vaccines

4.3 Market Restraints

4.3.1 Vaccine hesitancy and misinformation leading to lower vaccination rates

4.3.2 High cost of vaccine development and production

4.3.3 Regulatory challenges and approval processes delaying market entry for new vaccines

5 United States (US) Prophylactic Vaccines Market Trends

6 United States (US) Prophylactic Vaccines Market, By Types

6.1 United States (US) Prophylactic Vaccines Market, By Vaccine Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F

6.1.3 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F

6.1.4 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F

6.1.5 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F

6.1.6 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F

6.1.7 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F

6.1.8 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F

6.2 United States (US) Prophylactic Vaccines Market, By Disease

6.2.1 Overview and Analysis

6.2.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F

6.2.3 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F

6.2.4 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F

6.2.5 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F

6.2.6 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F

6.2.7 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F

6.2.8 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F

6.2.9 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F

6.3 United States (US) Prophylactic Vaccines Market, By Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F

6.3.3 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F

6.3.4 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F

6.3.5 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F

6.3.6 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F

6.4 United States (US) Prophylactic Vaccines Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F

6.5 United States (US) Prophylactic Vaccines Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F

6.5.4 United States (US) Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

7 United States (US) Prophylactic Vaccines Market Import-Export Trade Statistics

7.1 United States (US) Prophylactic Vaccines Market Export to Major Countries

7.2 United States (US) Prophylactic Vaccines Market Imports from Major Countries

8 United States (US) Prophylactic Vaccines Market Key Performance Indicators

8.1 Vaccination coverage rates among target populations

8.2 Research and development investment in new vaccine technologies

8.3 Disease incidence rates in vaccinated populations

9 United States (US) Prophylactic Vaccines Market - Opportunity Assessment

9.1 United States (US) Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

9.2 United States (US) Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F

9.3 United States (US) Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F

9.4 United States (US) Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 United States (US) Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 United States (US) Prophylactic Vaccines Market - Competitive Landscape

10.1 United States (US) Prophylactic Vaccines Market Revenue Share, By Companies, 2024

10.2 United States (US) Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Prophylactic Vaccines Market

Equatorial Guinea Prophylactic Vaccines Market

Eritrea Prophylactic Vaccines Market

Estonia Prophylactic Vaccines Market

Fiji Prophylactic Vaccines Market

Gabon Prophylactic Vaccines Market

Global Prophylactic Vaccines Market

Middle East Prophylactic Vaccines Market

North America Prophylactic Vaccines Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here